EU/3/20/2308

About

On 21 August 2020, orphan designation EU/3/20/2308 was granted by the European Commission to MDTB Cells GmbH, Germany, for allogeneic umbilical cord tissue-derived mesenchymal stromal cells ex vivo expanded for the prevention of bronchopulmonary dysplasia.

Key facts

Active substance
Allogeneic umbilical cord tissue-derived mesenchymal stromal cells ex vivo expanded
Disease / condition
Prevention of bronchopulmonary dysplasia
Date of first decision
21/08/2020
Outcome
Positive
EU designation number
EU/3/20/2308

Review of designation

The Committee for Orphan Medicinal Products reviews the orphan designation of a product if it is approved for marketing authorisation.

Sponsor's contact details

MDTB Cells GmbH
Meissner Strasse 55
01445 Radebeul
Germany
Tel: +4935121716215
E-mail: tino.hammer@mdtbcells.com

Patients' organisations

For contact details of patients’ organisations whose activities are targeted at rare diseases, see:

  • European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.

  • Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.

How useful was this page?

Add your rating